BIOLIFE SOLUTIONS INC - Form 4 Filing

This filing details a transaction by Mathew Aby J., EVP & Chief Scientific Officer of BIOLIFE SOLUTIONS INC. On September 8, 2026, Mr. Mathew disposed of 627 shares of Common Stock, which were withheld by the Issuer to satisfy tax obligations arising from the release of restricted stock units. The transaction occurred at a price of $35.38 per share. Following this transaction, Mr. Mathew holds 387,833 shares of BIOLIFE SOLUTIONS INC. common stock.